The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SOLE (Study of Letrozole Extension): A phase III randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC).
 
Marco Colleoni
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Celldex; OBI Pharma; Pfizer; Pierre Fabre; Puma Biotechnology
 
Weixiu Luo
No Relationships to Disclose
 
Per Karlsson
Consulting or Advisory Role - Novartis
 
Jacqueline H. Chirgwin
No Relationships to Disclose
 
Stefan Paul Aebi
No Relationships to Disclose
 
Guy Heinrich Maria Jerusalem
Honoraria - Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Novartis; Pfizer; Roche
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Patrick Neven
No Relationships to Disclose
 
Erika Hitre
No Relationships to Disclose
 
Marie-Pascale Graas
No Relationships to Disclose
 
Edda Simoncini
No Relationships to Disclose
 
Claus Kamby
No Relationships to Disclose
 
Alastair Mark Thompson
Travel, Accommodations, Expenses - Novartis (I)
 
Sibylle Loibl
No Relationships to Disclose
 
Joaquín Gavilá
No Relationships to Disclose
 
Katsumasa Kuroi
No Relationships to Disclose
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; Celgene; GlaxoSmithKline; Novartis; OBI Pharma; Roche
Consulting or Advisory Role - Accelsiors
Research Funding - AstraZeneca; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Eisai; Novartis; Pfizer
 
Manuela Rabaglio-Poretti
No Relationships to Disclose
 
Meredith M. Regan
Consulting or Advisory Role - Ipsen (Inst); Merck
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); OncoGenex (Inst); Pfizer (Inst); Pierre Fabre (Inst); Veridex (Inst)
 
Alan S. Coates
No Relationships to Disclose
 
Aron Goldhirsch
No Relationships to Disclose